Active Biotech's drug for the treatment of Multiple Sclerosis.Business Editors LUND, Sweden--(BUSINESS WIRE)--May 31, 2002 With reference to a press release sent out by Medivir May 29th 2002 regarding "Proof of principle" for a new orally active drug for the treatment of MS, Active Biotech would like to clarify the following: Active Biotech's drug for the treatment of MS, SAIK-MS, is currently in clinical Phase II, where the efficacy is verified on MS patients. The ongoing study is a multi-center study where 180 patients are planned to be included from England, Holland, Russia and Sweden. In the area of development of orally active drugs for the treatment of MS, Active Biotech has consequently the furthest advanced project of all companies internationally. Active Biotech estimates, that from gaining positive results during the pre-clinical optimisation phase, it takes approximately five years before clinical studies on MS patients potentially can be performed. The market for MS drugs is estimated to 2.3 billion US dollar (UBS UBS Union Bank of Switzerland UBS United Bible Societies UBS United Blood Services UBS United Buying Service UBS Used Bookstore UBS University Business Services UBS Universal Building Society (UK) UBS Ulaanbaatar Broadcasting System Warburg April 2001) distributed among Schering, Biogen, Serono and Teva. All these companies market injectable in·ject·a·ble adj. Capable of being injected. Used of a drug. n. A drug or medicine that can be injected. drugs though, which show a limited effect on the disease MS. Active Biotech, www.activebiotech.com is a biotechnology company focusing on research in and development of pharmaceuticals. Active Biotech has a strong R&D portfolio and pipeline products with focus primarily on autoimmune/inflammatory diseases and cancer. Most advanced projects (clinical trials phase II) include orally administered small molecules with unique immunomodulatory properties that can be used to treat autoimmune and inflammatory diseases Noun 1. inflammatory disease - a disease characterized by inflammation disease - an impairment of health or a condition of abnormal functioning NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants; (SAIK SAIK Sandvikens Aik ), as well as a novel concept for use in cancer immunotherapy Cancer immunotherapy is the use of the immune system to reject cancer. The main premise is stimulating the patient's immune system to attack the malignant tumor cells that are responsible for the disease. (TTS (1) See text-to-speech. (2) (Transaction Tracking System) Software that monitors a transaction until completion. In the event of a hardware or software failure, it ensures that the database is brought back to its former state before the attempt to ). |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion